Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
07/20/1999 | US5925733 DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis |
07/20/1999 | US5925731 Endothelin antagonist peptides |
07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
07/20/1999 | US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient. |
07/20/1999 | US5925566 Signal transduction polypeptide with two zinc finger domains; binds to epidermal growth factor receptor and released after activation to localize in nucleolus; anticarcinogenic agents; angiogenesis inhibitors |
07/20/1999 | US5925564 Expression vector systems and method of use |
07/20/1999 | US5925559 Phagemids and process of preparation |
07/20/1999 | US5925558 Assays for protein kinases using fluorescent protein substrates |
07/20/1999 | US5925555 Propagating virus with reverse transcriptase activity in brain cells |
07/20/1999 | US5925553 Ternary complex of zinc, catalytic site of enzyme, and heterocyclic inhibitory compound; antiarthritic agents |
07/20/1999 | US5925549 Soluble 7-transmembrane domain G-protein-coupled receptor compositions and methods |
07/20/1999 | US5925548 Disclosed are various dna, protein and cellular compositions and methods of making and using such constitutively active receptors. |
07/20/1999 | US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins |
07/20/1999 | US5925546 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
07/20/1999 | US5925542 Nucleic acid encoding human phosphodiesterase regulatory subunit |
07/20/1999 | US5925540 Synthetic antifreeze peptide and synthetic gene coding for its production |
07/20/1999 | US5925539 Human pelota homolog |
07/20/1999 | US5925536 Receptor-type phosphotyrosine phosphatase-β |
07/20/1999 | US5925533 Tropinin I calibrator and method of use thereof in a sandwich immunoassay |
07/20/1999 | US5925529 The inventive detection system involves the use of a ?tethered? ligand for probing receptor binding. |
07/20/1999 | US5925528 Murine cell lines which over produce acidic fibroblast growth factor (aFGF) and method of using same |
07/20/1999 | US5925526 Paraneoplastic cerebellar degeneration (pcd) is a disorder of the cerebellum found in association with neoplasms usually of lung, ovary, breast, or hodgkins disease. |
07/20/1999 | US5925522 Salmonella nucleotide sequences, methods of detection of salmonella nucleotide sequences, and method of detection of salmonella |
07/20/1999 | US5925516 Medicaments for the treatment of papillomavirus diseases |
07/20/1999 | US5925513 Diagnosis and treatment of AIDS onset |
07/20/1999 | US5925512 Monoclonal antibody which specifically binds to mutant hepatitis b virus surface antigen ?a? determinant |
07/20/1999 | US5925362 Method to elicit an antitumor response with human prostate-specific antigen |
07/20/1999 | US5925360 Isolated dna sequence encoding protein of hog cholera virus or antigenic fragment comprising specified amino acid sequence |
07/20/1999 | US5925358 Insertion of dna into fowlpox virus genome |
07/20/1999 | US5925352 Administering antiinflammatory amount of anti-neutrophil chemotactic factor antibodies |
07/20/1999 | US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
07/20/1999 | US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis |
07/20/1999 | US5925343 Canine granulocyte macrophage colony stimulating factor |
07/20/1999 | US5925333 Screening for compounds that alter the binding by scavengers |
07/20/1999 | US5925331 Technetium-99m labeled peptides for thrombus imaging |
07/20/1999 | CA2155001C Htlv-i and htlv-ii gp21 derived peptides for use in diagnostics |
07/20/1999 | CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria |
07/20/1999 | CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
07/20/1999 | CA2069043C Quantitation of samples utilizing capillary electrophoresis |
07/20/1999 | CA2053921C Synthetic peptides for an hiv-1 vaccine |
07/20/1999 | CA1340661C Respriatory synctial virus: vaccines and diagnostic assays |
07/20/1999 | CA1340656C Membrane anchor/active compound conjugate, its preparation and its use |
07/15/1999 | WO1999035292A1 Compositions and methods for treating cells having double minute dna |
07/15/1999 | WO1999035291A1 Isothermal transcription based amplification assay for the detection and quantitation of macrophage derived chemokine rna |
07/15/1999 | WO1999035279A1 G protein-related kinase mutants in essential hypertension |
07/15/1999 | WO1999035273A1 The process for expression and production of recombinant protein gp90 derived from glicoprotein envelop of equine infectious anemia virus eiav |
07/15/1999 | WO1999035272A1 RECOMBINANT P37/FlaA AS A DIAGNOSTIC REAGENT |
07/15/1999 | WO1999035270A1 Streptococcal heat shock proteins of the hsp60 family |
07/15/1999 | WO1999035269A2 Method for controlling the division and/or elongation of eukariotic cells |
07/15/1999 | WO1999035268A1 IL-1 delta DNA AND POLYPEPTIDES |
07/15/1999 | WO1999035267A1 Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides |
07/15/1999 | WO1999035266A2 Human urotensin ii |
07/15/1999 | WO1999035265A1 Human vps35/mem3-related protein |
07/15/1999 | WO1999035264A1 H14 dna and polypeptides |
07/15/1999 | WO1999035263A2 Il-17rh dna and polypeptides |
07/15/1999 | WO1999035262A2 Apoptosis inducing molecule ii |
07/15/1999 | WO1999035260A1 Non-identical genes and their application in improved molec ular adjuvants |
07/15/1999 | WO1999035259A1 Identification of lysolipid receptors involved in inflammatory response |
07/15/1999 | WO1999035258A1 Nucleic acid markers for apospory-specific genomic region |
07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
07/15/1999 | WO1999035241A1 Transgenic rabbit that expresses a functional human lipoprotein (a) |
07/15/1999 | WO1999035170A2 Compositions and methods for the treatment of tumor |
07/15/1999 | WO1999035169A2 Methods and compositions for treating and diagnosing insulin related disorders |
07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
07/15/1999 | WO1999035167A1 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients |
07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
07/15/1999 | WO1999035165A1 Secreted proteins and polynucleotides encoding them |
07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
07/15/1999 | WO1999035159A1 Lymphoma/leukemia oncogene, oncoprotein and methods of use |
07/15/1999 | WO1999035158A1 36 human secreted proteins |
07/15/1999 | WO1999035106A2 Mammalian edg-7 receptor homologs |
07/15/1999 | WO1999034836A1 Methods of controlling cell differentiation and growth using a fusion protein and a drug |
07/15/1999 | WO1999034826A1 Methods and compositions for desensitisation |
07/15/1999 | WO1999034825A1 Fertility impairing vaccine and method of use |
07/15/1999 | WO1999034822A1 Formulations for amylin agonist peptides |
07/15/1999 | WO1999034819A2 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases |
07/15/1999 | WO1999034818A1 Broad spectrum chemokine antagonist and uses thereof |
07/15/1999 | WO1999034816A1 Method for administering monomeric insulin analogs |
07/15/1999 | WO1999034815A1 Method for administering aspb28-human insulin |
07/15/1999 | WO1999034814A1 Interferon responsive transcript |
07/15/1999 | WO1999034670A1 Gene mutant animals |
07/15/1999 | WO1999029729A3 Antagonists of neuropilin receptor function and use thereof |
07/15/1999 | WO1999028466A8 Compositions and methods of use of het |
07/15/1999 | WO1999025857A3 Transgenic models of inflammatory disease |
07/15/1999 | WO1999025837A3 Method for producing virus-like particles on the basis of polyoma viruses |
07/15/1999 | WO1999025823A3 Recombinant allergen with reduced enzymatic activity |
07/15/1999 | WO1999025734A3 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
07/15/1999 | WO1999024573A3 SOYBEAN HOMOLOG OF SEED-SPECIFIC TRANSCRIPTION ACTIVATOR FROM $i(PHASEOLUS VULGARIS) |
07/15/1999 | WO1999024466A3 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
07/15/1999 | WO1999023867A3 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
07/15/1999 | WO1999021992A9 Nucleic acid molecules encoding a glutamate receptor |
07/15/1999 | WO1999018990A9 The il-1 receptor related protein 3 (il-1rrp3) |
07/15/1999 | WO1999018216A9 Chimeric vaccine against tick-borne encephalitis virus |
07/15/1999 | WO1999016298A9 Nepovirus resistance in grapevine |
07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
07/15/1999 | WO1998053066A9 Smad2 phosphorylation and interaction with smad4 |
07/15/1999 | DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum |
07/15/1999 | DE19800363A1 New inhibitors of serine protease useful for treating inflammation |